nach oben

Erschienen in:

06.02.2018 | Brief Report

Mutation of I176R in the E coding region weakens Japanese encephalitis virus neurovirulence, but not its growth rate in BHK-21 cells

verfasst von: Yuyong Zhou, Rui Wu, Qin Zhao, Yung-Fu Chang, Xintian Wen, Yao Feng, Xiaobo Huang, Yiping Wen, Qigui Yan, Yong Huang, Xiaoping Ma, Xinfeng Han, Sanjie Cao

Erschienen in: Archives of Virology | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Previously, we isolated the Japanese encephalitis virus (JEV) strain SCYA201201. In this study, we passed the SCYA201201 strain in Syrian baby hamster kidney (BHK-21) cells 120 times to obtain the SCYA201201-0901 strain, which exhibited an attenuated phenotype in mice. Comparison of SCYA201201-0901 amino acid sequences with those of other JEV strains revealed a single mutation, I176R, in the E coding region. Using reverse genetic technology, we provide evidence that this single E-I176R mutation does not affect virus growth in BHK-21 cells but significantly decreases JEV neurovirulence in mice. This study provides critical information for understanding the molecular mechanism of JEV attenuation.

Xin YY, Ming ZG, Peng GY, Jian A, Min LH (1988) Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. Am J Trop Med Hyg 39(2):214–217CrossRefPubMed

Yun SI, Song BH, Polejaeva IA, Davies CJ, White KL, Lee YM (2016) Comparison of the live-attenuated Japanese encephalitis vaccine SA14-14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo. J Gen Virol 97(10):2575CrossRefPubMed

Ni H, Burns NJ, Chang GJ, Zhang MJ, Wills MR, Trent DW, Sanders PG, Barrett AD (1994) Comparison of nucleotide and deduced amino acid sequence of the 5′ non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives. J Gen Virol 75(Pt 6):1505CrossRefPubMed

Zhao Z, Date T, Li Y, Kato T, Miyamoto M, Yasui K, Wakita T (2005) Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone. J Gen Virol 86(8):2209–2220CrossRefPubMed

Gromowski GD, Firestone CY, Whitehead SS (2015) Genetic determinants of Japanese encephalitis virus vaccine strain SA14-14-2 that govern attenuation of virulence in mice. J Virol 89(12):6328–6337CrossRefPubMedPubMedCentral

Tajima S, Nerome R, Nukui Y, Kato F, Takasaki T, Kurane I (2010) A single mutation in the Japanese encephalitis virus E protein (S123R) increases its growth rate in mouse neuroblastoma cells and its pathogenicity in mice. Virology 396(2):298–304CrossRefPubMed

Lindenbach BD, Thiel HJ, Rice CM (2007) Flaviviridae: the viruses and their replication. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (eds) Fields virology, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1101–1152

Yu YX (2010) Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities. Vaccine 28(21):3635–3641CrossRefPubMed

Yang J, Yang H, Li Z, Wang W, Lin H, Liu L, Ni Q, Liu X, Zeng X, Wu Y (2017) Envelope protein mutations L107F and E138K are important for neurovirulence attenuation for japanese encephalitis virus SA14-14-2 strain. Viruses 9(1):20CrossRefPubMedCentral

10.

Arroyo J, Guirakhoo F, Fenner S, Zhang ZX, Monath TP, Chambers TJ (2001) Molecular basis for attenuation of neurovirulence of a yellow fever virus/japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol 75(2):934–942CrossRefPubMedPubMedCentral

11.

Yuan L, Wu R, Liu H, Wen X, Huang X, Wen Y, Ma X, Yan Q, Huang Y, Zhao Q (2016) Tissue tropism and molecular characterization of a Japanese encephalitis virus strains isolated from pigs in southwest China. Virus Res 215:55–64CrossRefPubMed

12.

Solomon T, Ni H, Beasley DW, Ekkelenkamp M, Cardosa MJ, Barrett AD (2003) Origin and evolution of Japanese encephalitis virus in southeast Asia. J Virol 77(5):3091–3098CrossRefPubMedPubMedCentral

13.

Pujhari SK, Prabhakar S, Ratho RK, Modi M, Sharma M, Mishra B (2011) A novel mutation (S227T) in domain II of the envelope gene of Japanese encephalitis virus circulating in North India. Epidemiol Infect 139(6):849–856CrossRefPubMed

14.

Lee E, Lobigs M (2000) Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry. J Virol 74(19):8867–8875CrossRefPubMedPubMedCentral

15.

Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, Marks RM (1997) Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3(8):866–871CrossRefPubMed

Titel: Mutation of I176R in the E coding region weakens Japanese encephalitis virus neurovirulence, but not its growth rate in BHK-21 cells
verfasst von: Yuyong Zhou
Rui Wu
Qin Zhao
Yung-Fu Chang
Xintian Wen
Yao Feng
Xiaobo Huang
Yiping Wen
Qigui Yan
Yong Huang
Xiaoping Ma
Xinfeng Han
Sanjie Cao
Publikationsdatum: 06.02.2018
Verlag: Springer Vienna
Erschienen in: Archives of Virology / Ausgabe 5/2018
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-018-3765-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Mutation of I176R in the E coding region weakens Japanese encephalitis virus neurovirulence, but not its growth rate in BHK-21 cells

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2018

Experimental infection of Marmota monax with a novel hepatitis A virus

Human bocavirus in hospitalized children under 5 years with acute respiratory infection, São Paulo, Brazil, 2010

Genetic analysis of rotavirus G2P[4] strains in Pune, Western India: circulation of a novel reassortant bearing E6 NSP4 genotype

Evidence for a complex of emergent poleroviruses affecting pepper worldwide

Problems of classification in the family Paramyxoviridae

Isobavachalcone inhibits post-entry stages of the porcine reproductive and respiratory syndrome virus life cycle

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin